FDA Inspection 1275297 — Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V.

Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V. — FEI 3002744909

The FDA completed an inspection of Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V. on June 27, 2025 in Naucalpan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Naucalpan (Mexico)

Citations

IDCFRDescription
202321 CFR 211.188(b)(11)Identification of Persons Performing Significant Steps
202721 CFR 211.192Investigations of discrepancies, failures